Predicting outcomes with pembrolizumab: a meta-analysis of pre-treatment hematological and clinical prognostic factors in advanced/metastatic urothelial carcinoma. Archivio Italiano di Urologia e Andrologia, v. 97, n. 2, 16 Jun.2025.